Comparison of safety and efficacy of intracoronary bolus abciximab only vs standard intravenous bolus and infusion abciximab in patients with myocardial infarction undergoing percutaneous coronary intervention
Transcatheter Cardiovascular Therapeutics
Saved in:
Main Authors: | Ngo, Minh Hung, Tjandra Sewianto, Teo, Swee Guan, Low, Fatt Hoe Adrian, Lee, C.-H., Tan, Huay Cheem |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/123965 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Comparison between fixed-dose, intracoronary bolus-only versus standard weight-adjusted dose, intravenous bolus and infusion administration of abciximab in patients undergoing primary percutaneous coronary intervention
by: Lee, C.-H., et al.
Published: (2011) -
Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study
by: Wong, A., et al.
Published: (2016) -
Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention
by: Razakjr, O.A., et al.
Published: (2014) -
Comparison of the X-SIZER thrombectomy device with adjunct abciximab during primary angioplasty and stenting for ST-segment elevation myocardial infarction
by: Low, A.F., et al.
Published: (2011) -
The use of abciximab in coronary angioplasty - An Asian centre's experience
by: Tan, H.C., et al.
Published: (2014)